Content area
Full Text
KEY WORDS: embryonic, stem cells, regulation, embryos, hESC.
The ethical debate regarding human embryonic Stem cell (hESC) research has echoed around the globe without a consensus. While there is wide recognition of the part that such research could potentially play in the development of treatments for neurodegenerative disorders, such as Parkinson's and Alzheimer's diseases, and many other debilitating and devastating illnesses, including coronary disease, cancer, and diabetes, there is considerable disparity between countries with regard to regulatory control of hESC research and the public funding for it. Some of these disparities perhaps arise from the disproportionate influence of some of the stakeholders interested in the regulation of how hESC research can be conducted and the public resources for its funding. However, such disparities are also sometimes mirrored in the commitment of a...